Bill Status of HB 5103   103rd General Assembly

Short Description:  INS CD-CANCER SCREENINGS

House Sponsors
Rep. Jed Davis-Kelly M. Cassidy

Last Action  View All Actions

DateChamber Action
  4/5/2024HouseRule 19(a) / Re-referred to Rules Committee

Statutes Amended In Order of Appearance
215 ILCS 5/356u

Synopsis As Introduced
Amends the Illinois Insurance Code. In a provision concerning coverage of certain cancer screenings, adds having a high level of CA-125, as indicated by a blood test screening, to the definition of "at risk for ovarian cancer". Provides that "surveillance tests for ovarian cancer" means all medically viable methods for the detection and diagnosis of ovarian cancer, including, but not limited to, ultrasounds, magnetic resonance imagings (MRIs), x-rays, computed tomography (CT) scans, and CA-125 blood test screenings (instead of an annual screening using (i) CA-125 serum tumor marker testing, (ii) transvaginal ultrasound, (iii) pelvic examination).

Actions 
DateChamber Action
  2/8/2024HouseFiled with the Clerk by Rep. Jed Davis
  2/8/2024HouseAdded Chief Co-Sponsor Rep. Kelly M. Cassidy
  2/8/2024HouseFirst Reading
  2/8/2024HouseReferred to Rules Committee
  2/28/2024HouseAssigned to Insurance Committee
  2/29/2024HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Jed Davis
  2/29/2024HouseHouse Committee Amendment No. 1 Referred to Rules Committee
  3/12/2024HouseHouse Committee Amendment No. 1 Rules Refers to Insurance Committee
  3/13/2024HouseTo Insurance Main Subcommittee
  4/5/2024HouseRule 19(a) / Re-referred to Rules Committee
  4/5/2024HouseHouse Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee

Back To Top